Epidemiology of anaphylaxis

Clinical and Experimental Allergy

Volumn 45, Issue 6, 2015, Pages 1027-1039

  Tejedor Alonso, M A ^a,b   Moro Moro, M ^a   Mugica Garcia M V ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FOOD ALLERGEN; HYMENOPTERA VENOM; ALLERGEN;

ALLERGIC ASTHMA; ALLERGIC REACTION; ANAPHYLAXIS; ATOPY; CARDIOVASCULAR SYMPTOM; COMORBIDITY; DRUG HYPERSENSITIVITY; EGG ALLERGY; HOSPITAL PATIENT; ICD-9-CM; INCIDENCE; INSECT STING; MILK ALLERGY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; AGE; HUMAN; IMMUNOLOGY; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; ALLERGENS; ANAPHYLAXIS; HUMANS; INCIDENCE; MORTALITY; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 84929310096     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12418     Document Type: Review

References (110)

1. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 2007; 98:360-5.
2. Brown AT, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 2001; 108:861-6.
3. Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. BMJ 2000; 320:1441.
4. International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003; 12:195-202.
5. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 2005; 28:381-8.
6. Braganza SC, Acworth JP, Mckinnon DR, Peake JE, Brown AF. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91:159-63.
7. Moro Moro M, Tejedor Alonso MA, Esteban Hernandez J, Mugica Garcia MV, Rosado Ingelmo A, Vila Albelda C. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol 2011; 21:142-9.
8. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 2006; 97:39-43.
9. Tejedor Alonso MA, Moro MM, Hernandez JE et al. Incidence of anaphylaxis in hospitalized patients. Int Arch Allergy Immunol 2011; 156:212-20.
10. Gupta R, Sheikh A, Strachan D, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003; 327:1142-3.
11. Jirapongsananuruk O, Bunsawansong W, Piyaphanee N, Visitsunthorn N, Thongngarm T, Vichyanond P. Features of patients with anaphylaxis admitted to a university hospital. Ann Allergy Asthma Immunol 2007; 98:157-62.
12. Mulla ZD, Simon MR. Hospitalizations for anaphylaxis in Florida: epidemiologic analysis of a population-based dataset. Int Arch Allergy Immunol 2007; 144:128-36.
13. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120:878-84.
14. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009; 123:434-42.
15. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004; 164:317-9.
16. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010; 125:1098-104.e1.
17. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101:139-43.
18. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999; 104(2 Pt 1):452-6.
19. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940, 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34:285-90.
20. Decker WW, Campbell RL, Manivannan V et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122:1161-5.
21. Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV et al. Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study. Clin Exp Allergy 2012; 42:578-89.
22. Bohlke K, Davis RL, DeStefano F et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004; 113:536-42.
23. Wood RA, Camargo CA Jr, Lieberman P et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:461-7.
24. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53:273-6.
25. Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 2003; 112:451-2.
26. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004; 4:285-90.
27. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004; 257:116-28; discussion 128-32, 157-60, 276-85.
28. Pumphrey RSGM. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119:1018-9.
29. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34:520-6.
30. Mullins RJ, Clark S, Camargo CA Jr. Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypothesis. Ann Allergy Asthma Immunol 2009; 103:488-95.
31. Camargo CA Jr, Clark S, Kaplan MS et al. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol 2007; 120:131-6.
32. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 2002; 110:647-51.
33. Cianferoni A, Novembre E, Pucci N, Lombardi E, Bernardini R, Vieruci A. Anaphylaxis: a 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol 2004; 92:464-8.
34. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 2003; 33:1033-40.
35. Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000; 106(1 Pt 1):171-6.
36. Mulla ZD, Lin RY, Simon MR. Perspectives on anaphylaxis epidemiology in the United States with new data and analyses. Curr Allergy Asthma Rep 2011; 11:37-44.
37. Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008; 63:1077-83.
38. Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy 2012; 67:783-9.
39. Schneider G, Kachroo S, Jones N et al. A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data. Pharmacoepidemiol Drug Saf 2012; 21(Suppl. 1):240-7.
40. Walsh KE, Cutrona SL, Foy S et al. Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. Pharmacoepidemiol Drug Saf 2013; 22:1205-13.
41. Stewart AG, Ewan PW. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. QJM 1996; 89:859-64.
42. Cianferoni A, Novembre E, Mugnaini L et al. Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). Ann Allergy Asthma Immunol 2001; 87:27-32.
43. Vetander M, Helander D, Flodstrom C et al. Anaphylaxis and reactions to foods in children-a population-based case study of emergency department visits. Clin Exp Allergy 2012; 42:568-77.
44. Rangaraj S, Tuthill D, Burr M, Alfaham M. Childhood epidemiology of anaphylaxis and epinephrine prescriptions in Wales: 1994-1999. J Allergy Clin Immunol 2002; 109(Suppl. 1):S75.
45. Lieberman P. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 8:316-20.
46. Lieberman P, Camargo CA Jr, Bohlke K et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006; 97:596-602.
47. Muraro A, Roberts G, Clark A et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62:857-71.
48. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 115:575-83.
49. Panesar SS, Javad S, de Silva D et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68:1353-61.
50. Capps JA, Sharma V, Arkwright PD. Prevalence, outcome and pre-hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester, UK. Resuscitation 2010; 81:653-7.
51. Quercia O, Incorvaia C, Puccinelli P et al. Prevalence of allergic disorders in Italy: the Cotignola population study. Eur Ann Allergy Clin Immunol 2012; 44:5-11.
52. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 2001; 31:1571-6.
53. Clark S, Camargo CA Jr. Epidemiology of anaphylaxis. Immunol Allergy Clin North Am 2007; 27:145-63, v.
54. Sampson HA, Munoz-Furlong A, Bock SA et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584-91.
55. Sampson HA, Muñoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report - second National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-7.
56. Campbell RL, Hagan JB, Manivannan V et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol 2012; 129:748-52.
57. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2010; 126:98-104.e4.
58. Harduar-Morano L, Simon MR, Watkins S, Blackmore C. A population-based epidemiologic study of emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2011; 128:594-600.
59. Boros CA, Kay D, Gold MS. Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paediatr Child Health 2000; 36:36-40.
60. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children-a questionnaire-based survey in Germany. Allergy 2005; 60:1440-5.
61. Eagan TM, Brogger JC, Eide GE, Bakke PS. The incidence of adult asthma: a review. Int J Tuberc Lung Dis 2005; 9:603-12.
62. Lieberman PL. Recognition and first-line treatment of anaphylaxis. Am J Med 2014; 127(Suppl.):S6-11.
63. Clark S, Gaeta TJ, Kamarthi GS, Camargo CA. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 2006; 16:696-700.
64. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. 2004. J Allergy Clin Immunol 2004; 113:347-53.
65. Clark S, Long AA, Gaeta TJ, Camargo CA Jr. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol 2005; 116:643-9.
66. Simon MR, Mulla ZD. Hospitalizations for anaphylaxis in Florida: analysis of month of discharge. Int Arch Allergy Immunol 2008; 146:89-90.
67. San Miguel-Moncín MM, García-Figueroa B, Sanz-Larruga EM, Lasa-Luaces EM. Concepto, epidemiología y fisiopatología de la alergia a los alimentos. In: Peláez-Hernández A, Dávila-González I, eds. Tratado de Alergología. 1st Edn. Madrid: Ergon; 2007: 789.
68. Allen KJ, Koplin JJ. The epidemiology of IgE-mediated food allergy and anaphylaxis. Immunol Allergy Clin North Am 2012; 32:35-50.
69. Crespo JF, Pascual C, Burks AW, Helm RM, Esteban MM. Frequency of food allergy in a pediatric population from Spain. Pediatr Allergy Immunol 1995; 6:39-43.
70. Iikura Y, Imai Y, Imai T et al. Frequency of immediate-type food allergy in children in Japan. Int Arch Allergy Immunol 1999; 118:251-2.
71. Dalal I, Binson I, Reifen R et al. Food allergy is a matter of geography after all: sesame as a major cause of severe IgE-mediated food allergic reactions among infants and young children in Israel. Allergy 2002; 57:362-5.
72. Schafer T, Bohler E, Ruhdorfer S et al. Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy 2001; 56:1172-9.
73. Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 2003; 112:1203-7.
74. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113:805-19.
75. Zuberbier T, Edenharter G, Worm M et al. Prevalence of adverse reactions to food in Germany - a population study. Allergy 2004; 59:338-45.
76. Gupta RS, Springston EE, Warrier MR et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 2011; 128:e9-17.
77. Gupta RS. Anaphylaxis in the young adult population. Am J Med 2014; 127(Suppl.):S17-24.
78. Hoyos-Bachiloglu R, Morales PS, Cerda J et al. Higher latitude and lower solar radiation influence on anaphylaxis in Chilean children. Pediatr Allergy Immunol 2014; 25:338-43.
79. Rudders SA, Banerji A, Corel B et al. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics 2010; 125:e711-8.
80. Sheehan WJ, Graham D, Ma L, Baxi S, Phipatanakul W. Higher incidence of pediatric anaphylaxis in northern areas of the United States. J Allergy Clin Immunol 2009; 124:850-2.e2.
81. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007; 62:91-6.
82. Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133:1075-83.
83. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics 2009; 124:1549-55.
84. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol 2008; 101:387-93.
85. Iribarren C, Tolstykh IV, Miller MK, Eisner MD. Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol 2010; 104:371-7.
86. Khan DA, Yocum MW. Clinical course of idiopathic anaphylaxis. Ann Allergy 1994; 73:370-4.
87. Ditto AM, Harris KE, Krasnick J, Miller MA, Patterson R. Idiopathic anaphylaxis: a series of 335 cases. Ann Allergy Asthma Immunol 1996; 77:285-91.
88. Dibs SD, Baker MD. Anaphylaxis in children: a 5-year experience. Pediatrics 1997; 99:E7.
89. Novembre E, Cianferoni A, Bernardini R et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 1998; 101:E8.
90. Shadick NA, Liang MH, Partridge AJ et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol 1999; 104:123-7.
91. Tejedor Alonso MA, Sastre DJ, Sanchez-Hernandez JJ, Perez FC, de la Hoz Caballer B. Idiopathic anaphylaxis: a descriptive study of 81 patients in Spain. Ann Allergy Asthma Immunol 2002; 88:313-8.
92. Gold MS. Anaphylaxis Working Party, Australasian Society of Clinical Immunology and Allergy. EpiPen epidemic or good clinical practice? J Paediatr Child Health 2003; 39:376-7.
93. Tejedor-Alonso M, Mugica-García M, Esteban-Hernández J et al. A study of recurrence of anaphylaxis in a spanish anaphylaxis series. J Investig Allergol Clin Immunol 2013; 23:383-91.
94. Demoly P, Hillaire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 2004; 24:345-6.
95. Fernández de Corres L, Del Pozo M, Aizpuru F, Buendía E. Prevalence of Anisakis simplex sensitisation in three Spanish areas, in relation to the fish intake rates. Relevance of Anisakis simplex allergy. Multicentre Study of the Spanish Society of Allergology and Clinical Immunology. Alergol Inmunol Clin 2001; 16:337-46.
96. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114:371-6.
97. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144-50.
98. Pumphrey RS. When should self-injectible epinephrine be prescribed for food allergy and when should it be used? Curr Opin Allergy Clin Immunol 2008; 8:254-60.
99. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60:443-51.
100. Ben-Shoshan M, Clarke AE. Anaphylaxis: past, present and future. Allergy 2011; 66:1-14.
101. Low I, Stables S. Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology 2006; 38:328-32.
102. Sampson HA, Mendelson LM, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380-4.
103. Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child 2002; 86:236-9.
104. Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119:1016-8.
105. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-3.
106. Foucard T, Malmheden Yman I. A study on severe food reactions in Sweden - is soy protein an underestimated cause of food anaphylaxis?. Allergy 1999; 54:261-5.
107. Summers C, Pumphrey RSH, Woods CN et al. Factors predicting anaphylaxisto peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol 2008; 121:631-8.
108. Tang ML, Osborne N, Allen K. Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2009; 9:351-6.
109. Janson C, Anto J, Burney P et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18:598-611.
110. Asher MI, Montefort S, Bjorksten B et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368:733-43.